Literature DB >> 15198936

Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance.

Yuren Wei1, Michael J Pagliassotti.   

Abstract

Sucrose- and fructose-enriched diets produce hepatic insulin resistance in rats independently of obesity. In humans, fructose infusion results in impaired insulin regulation of glucose production. The aim of the present study was to identify intrahepatic mediators of sucrose- and fructose-induced hepatic insulin resistance. In study 1, male rats were fed a control diet (STD, 68% of energy from corn starch, 12% from corn oil) or a sucrose-enriched diet (HSD, 68% sucrose, 12% corn oil) for 1, 2, or 5 wk. HSD produced hepatic insulin resistance at all time points. Hepatic protein tyrosine phosphatase 1B protein levels and activity were increased at 5 wk only, whereas c-jun NH(2)-terminal kinase (JNK) activity was increased at all time points. Normalization of JNK activity in hepatocytes isolated from HSD rats improved insulin-stimulated tyrosine phosphorylation of insulin receptor substrate (IRS) proteins and insulin suppression of glucose release. In study 2, male rats were provided STD for 1 wk and then were either fasted or fasted and refed either STD or HSD for 3 or 6 h. Rats refed HSD were characterized by increased hepatic JNK activity and phosphorylation of IRS1 on Ser(307) after 6 h only. In study 3, hyperglycemic, hyperinsulinemic pancreatic clamps were performed for 3 or 6 h in the presence or absence of low or high intraportal fructose infusions. High intraportal fructose infusions, which increased portal vein fructose concentration to approximately 1 mM, increased hepatic JNK activity and phosphorylation of IRS1 on Ser(307) at 6 h only. These data suggest that sucrose- and fructose-induced hepatic insulin resistance are mediated, in part, via activation of JNK activity. Thus high rates of fructose metabolism in the liver appear to acutely activate stress pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198936     DOI: 10.1152/ajpendo.00185.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  29 in total

Review 1.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.

Authors:  Jung Sub Lim; Michele Mietus-Snyder; Annie Valente; Jean-Marc Schwarz; Robert H Lustig
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

2.  Fructose-enriched diet induces inflammation and reduces antioxidative defense in visceral adipose tissue of young female rats.

Authors:  Sanja Kovačević; Jelena Nestorov; Gordana Matić; Ivana Elaković
Journal:  Eur J Nutr       Date:  2015-10-03       Impact factor: 5.614

Review 3.  Fructose and hepatic insulin resistance.

Authors:  Samir Softic; Kimber L Stanhope; Jeremie Boucher; Senad Divanovic; Miguel A Lanaspa; Richard J Johnson; C Ronald Kahn
Journal:  Crit Rev Clin Lab Sci       Date:  2020-01-14       Impact factor: 6.250

Review 4.  The role of high-fructose corn syrup in metabolic syndrome and hypertension.

Authors:  Leon Ferder; Marcelo Damián Ferder; Felipe Inserra
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

Review 5.  Fructose toxicity: is the science ready for public health actions?

Authors:  Luc Tappy; Bettina Mittendorfer
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-07       Impact factor: 4.294

6.  Hepatic inflammation induced by high-fructose diet is associated with altered 11βHSD1 expression in the liver of Wistar rats.

Authors:  Ana Vasiljević; Biljana Bursać; Ana Djordjevic; Danijela Vojnović Milutinović; Marina Nikolić; Gordana Matić; Nataša Veličković
Journal:  Eur J Nutr       Date:  2014-01-04       Impact factor: 5.614

7.  Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women.

Authors:  Michael M Swarbrick; Kimber L Stanhope; Sharon S Elliott; James L Graham; Ronald M Krauss; Mark P Christiansen; Steven C Griffen; Nancy L Keim; Peter J Havel
Journal:  Br J Nutr       Date:  2008-11       Impact factor: 3.718

8.  (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress.

Authors:  Ahmed Bettaieb; Marcela A Vazquez Prieto; Cecilia Rodriguez Lanzi; Roberto M Miatello; Fawaz G Haj; César G Fraga; Patricia I Oteiza
Journal:  Free Radic Biol Med       Date:  2014-04-16       Impact factor: 7.376

Review 9.  Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.

Authors:  Manoela Mota; Bubu A Banini; Sophie C Cazanave; Arun J Sanyal
Journal:  Metabolism       Date:  2016-03-03       Impact factor: 8.694

Review 10.  Stress hyperglycemia and enhanced sensitivity to myocardial infarction.

Authors:  Keith A Webster
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.